Era-Net (MOH): EP PerMed – Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)- Preproposals

EP PerMed will fund research projects in human health on innovative PM strategies for

patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. Proposals should address one or more of the

following aspects:

• Development and validation ofinnovative personalised therapeutic approachesfor cardiovascular, metabolic or kidney diseases through testing in relevant pre-clinical models
• Identification and validation of molecular markers/signatures or cutting-edge technologies

to monitor treatment response in patients with cardiovascular, metabolic or kidney diseases in order to tailor treatment pathways.

• Identification and validation of stratifying molecular markers/signatures or stratifying diagnostic technologiesfor early disease risk prediction and prevention of disease worsening or comorbiditiesin patients with cardiovascular, metabolic or kidney diseases, thereby delaying the progression to cardiovascular-kidney-metabolic syndrome.

Funding: up to 140K EUR for Israeli PIs

https://www.eppermed.eu/funding-projects/calls/jtc2026

* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1477).

An information webinar for potential applicants will take place on 16 December, 11:00–13:00 CET:

For registration: https://www.eppermed.eu/news-events/events/ep-permed-jtc2026-information-day/